Report Summary
Stem Cells Industry-United States Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Stem Cells Industry industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole United States and Regional Market Size of Stem Cells Industry 2013-2017, and development forecast 2018-2023
Main market players of Stem Cells Industry in United States, with company and product introduction, position in the Stem Cells Industry market
Market status and development trend of Stem Cells Industry by types and applications
Cost and profit status of Stem Cells Industry, and marketing status
Market growth drivers and challenges
The report segments the United States Stem Cells Industry market as:
United States Stem Cells Industry Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
New England
The Middle Atlantic
The Midwest
The West
The South
Southwest
United States Stem Cells Industry Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Allogeneic Stem Cell Therapy
Autologous Stem Cell Therapy
United States Stem Cells Industry Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Musculoskeletal Disorders
Metabolic Diseases
Immune System Diseases
GIT Diseases
Eye Diseases
CVS Diseases
CNS Diseases
Wounds and Injuries
Others
United States Stem Cells Industry Market: Players Segment Analysis (Company and Product introduction, Stem Cells Industry Sales Volume, Revenue, Price and Gross Margin):
ViaCyte, Inc.
Celgene Corporation
Thermo Fisher Scientific
Aastrom Biosciences, Inc.
Osiris Therapeutics, Inc.
Geron Corporation
Vericel Corporation
Astellas Pharma
StemCells, Inc.
Cytori Therapeutics, Inc.
Pluristem Therapeutics Inc.
Mesoblast Ltd.
Athersys
Fate Therapeutics Inc.
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Interested in this report?
Get your sample now!
Table of Contents
Chapter 1 Overview of Stem Cells Industry
1.1 Definition of Stem Cells Industry in This Report
1.2 Commercial Types of Stem Cells Industry
1.2.1 Allogeneic Stem Cell Therapy
1.2.2 Autologous Stem Cell Therapy
1.3 Downstream Application of Stem Cells Industry
1.3.1 Musculoskeletal Disorders
1.3.2 Metabolic Diseases
1.3.3 Immune System Diseases
1.3.4 GIT Diseases
1.3.5 Eye Diseases
1.3.6 CVS Diseases
1.3.7 CNS Diseases
1.3.8 Wounds and Injuries
1.3.9 Others
1.4 Development History of Stem Cells Industry
1.5 Market Status and Trend of Stem Cells Industry 2013-2023
1.5.1 United States Stem Cells Industry Market Status and Trend 2013-2023
1.5.2 Regional Stem Cells Industry Market Status and Trend 2013-2023
Chapter 2 United States Market Status and Forecast by Regions
2.1 Market Status of Stem Cells Industry in United States 2013-2017
2.2 Consumption Market of Stem Cells Industry in United States by Regions
2.2.1 Consumption Volume of Stem Cells Industry in United States by Regions
2.2.2 Revenue of Stem Cells Industry in United States by Regions
2.3 Market Analysis of Stem Cells Industry in United States by Regions
2.3.1 Market Analysis of Stem Cells Industry in New England 2013-2017
2.3.2 Market Analysis of Stem Cells Industry in The Middle Atlantic 2013-2017
2.3.3 Market Analysis of Stem Cells Industry in The Midwest 2013-2017
2.3.4 Market Analysis of Stem Cells Industry in The West 2013-2017
2.3.5 Market Analysis of Stem Cells Industry in The South 2013-2017
2.3.6 Market Analysis of Stem Cells Industry in Southwest 2013-2017
2.4 Market Development Forecast of Stem Cells Industry in United States 2018-2023
2.4.1 Market Development Forecast of Stem Cells Industry in United States 2018-2023
2.4.2 Market Development Forecast of Stem Cells Industry by Regions 2018-2023
Chapter 3 United States Market Status and Forecast by Types
3.1 Whole United States Market Status by Types
3.1.1 Consumption Volume of Stem Cells Industry in United States by Types
3.1.2 Revenue of Stem Cells Industry in United States by Types
3.2 United States Market Status by Types in Major Countries
3.2.1 Market Status by Types in New England
3.2.2 Market Status by Types in The Middle Atlantic
3.2.3 Market Status by Types in The Midwest
3.2.4 Market Status by Types in The West
3.2.5 Market Status by Types in The South
3.2.6 Market Status by Types in Southwest
3.3 Market Forecast of Stem Cells Industry in United States by Types
Chapter 4 United States Market Status and Forecast by Downstream Industry
4.1 Demand Volume of Stem Cells Industry in United States by Downstream Industry
4.2 Demand Volume of Stem Cells Industry by Downstream Industry in Major Countries
4.2.1 Demand Volume of Stem Cells Industry by Downstream Industry in New England
4.2.2 Demand Volume of Stem Cells Industry by Downstream Industry in The Middle Atlantic
4.2.3 Demand Volume of Stem Cells Industry by Downstream Industry in The Midwest
4.2.4 Demand Volume of Stem Cells Industry by Downstream Industry in The West
4.2.5 Demand Volume of Stem Cells Industry by Downstream Industry in The South
4.2.6 Demand Volume of Stem Cells Industry by Downstream Industry in Southwest
4.3 Market Forecast of Stem Cells Industry in United States by Downstream Industry
Chapter 5 Market Driving Factor Analysis of Stem Cells Industry
5.1 United States Economy Situation and Trend Overview
5.2 Stem Cells Industry Downstream Industry Situation and Trend Overview
Chapter 6 Stem Cells Industry Market Competition Status by Major Players in United States
6.1 Sales Volume of Stem Cells Industry in United States by Major Players
6.2 Revenue of Stem Cells Industry in United States by Major Players
6.3 Basic Information of Stem Cells Industry by Major Players
6.3.1 Headquarters Location and Established Time of Stem Cells Industry Major Players
6.3.2 Employees and Revenue Level of Stem Cells Industry Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
Chapter 7 Stem Cells Industry Major Manufacturers Introduction and Market Data
7.1 ViaCyte, Inc.
7.1.1 Company profile
7.1.2 Representative Stem Cells Industry Product
7.1.3 Stem Cells Industry Sales, Revenue, Price and Gross Margin of ViaCyte, Inc.
7.2 Celgene Corporation
7.2.1 Company profile
7.2.2 Representative Stem Cells Industry Product
7.2.3 Stem Cells Industry Sales, Revenue, Price and Gross Margin of Celgene Corporation
7.3 Thermo Fisher Scientific
7.3.1 Company profile
7.3.2 Representative Stem Cells Industry Product
7.3.3 Stem Cells Industry Sales, Revenue, Price and Gross Margin of Thermo Fisher Scientific
7.4 Aastrom Biosciences, Inc.
7.4.1 Company profile
7.4.2 Representative Stem Cells Industry Product
7.4.3 Stem Cells Industry Sales, Revenue, Price and Gross Margin of Aastrom Biosciences, Inc.
7.5 Osiris Therapeutics, Inc.
7.5.1 Company profile
7.5.2 Representative Stem Cells Industry Product
7.5.3 Stem Cells Industry Sales, Revenue, Price and Gross Margin of Osiris Therapeutics, Inc.
7.6 Geron Corporation
7.6.1 Company profile
7.6.2 Representative Stem Cells Industry Product
7.6.3 Stem Cells Industry Sales, Revenue, Price and Gross Margin of Geron Corporation
7.7 Vericel Corporation
7.7.1 Company profile
7.7.2 Representative Stem Cells Industry Product
7.7.3 Stem Cells Industry Sales, Revenue, Price and Gross Margin of Vericel Corporation
7.8 Astellas Pharma
7.8.1 Company profile
7.8.2 Representative Stem Cells Industry Product
7.8.3 Stem Cells Industry Sales, Revenue, Price and Gross Margin of Astellas Pharma
7.9 StemCells, Inc.
7.9.1 Company profile
7.9.2 Representative Stem Cells Industry Product
7.9.3 Stem Cells Industry Sales, Revenue, Price and Gross Margin of StemCells, Inc.
7.10 Cytori Therapeutics, Inc.
7.10.1 Company profile
7.10.2 Representative Stem Cells Industry Product
7.10.3 Stem Cells Industry Sales, Revenue, Price and Gross Margin of Cytori Therapeutics, Inc.
7.11 Pluristem Therapeutics Inc.
7.11.1 Company profile
7.11.2 Representative Stem Cells Industry Product
7.11.3 Stem Cells Industry Sales, Revenue, Price and Gross Margin of Pluristem Therapeutics Inc.
7.12 Mesoblast Ltd.
7.12.1 Company profile
7.12.2 Representative Stem Cells Industry Product
7.12.3 Stem Cells Industry Sales, Revenue, Price and Gross Margin of Mesoblast Ltd.
7.13 Athersys
7.13.1 Company profile
7.13.2 Representative Stem Cells Industry Product
7.13.3 Stem Cells Industry Sales, Revenue, Price and Gross Margin of Athersys
7.14 Fate Therapeutics Inc.
7.14.1 Company profile
7.14.2 Representative Stem Cells Industry Product
7.14.3 Stem Cells Industry Sales, Revenue, Price and Gross Margin of Fate Therapeutics Inc.
Chapter 8 Upstream and Downstream Market Analysis of Stem Cells Industry
8.1 Industry Chain of Stem Cells Industry
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
Chapter 9 Cost and Gross Margin Analysis of Stem Cells Industry
9.1 Cost Structure Analysis of Stem Cells Industry
9.2 Raw Materials Cost Analysis of Stem Cells Industry
9.3 Labor Cost Analysis of Stem Cells Industry
9.4 Manufacturing Expenses Analysis of Stem Cells Industry
Chapter 10 Marketing Status Analysis of Stem Cells Industry
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
Chapter 11 Report Conclusion
Chapter 12 Research Methodology and Reference
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
List of Tables
Table Advantage and Disadvantage of Allogeneic Stem Cell Therapy
Table Advantage and Disadvantage of Autologous Stem Cell Therapy
Table Consumption Volume of Stem Cells Industry in United States by Regions 2013-2017
Table Revenue of Stem Cells Industry in United States by Regions 2013-2017
Table Consumption Volume of Stem Cells Industry in United States by Regions 2018-2023
Table Revenue of Stem Cells Industry in United States by Regions 2018-2023
Table Consumption Volume of Stem Cells Industry in United States by Types 2013-2017
Table Revenue of Stem Cells Industry in United States by Types 2013-2017
Table Consumption Volume of Stem Cells Industry by Types in New England 2013-2017
Table Consumption Volume of Stem Cells Industry by Types in The Middle Atlantic 2013-2017
Table Consumption Volume of Stem Cells Industry by Types in The Midwest 2013-2017
Table Consumption Volume of Stem Cells Industry by Types in The West 2013-2017
Table Consumption Volume of Stem Cells Industry by Types in The South 2013-2017
Table Consumption Volume of Stem Cells Industry by Types in Southwest 2013-2017
Table Consumption Volume Forecast of Stem Cells Industry in United States by Types 2018-2023
Table Revenue Forecast of Stem Cells Industry in United States by Types 2018-2023
Table Demand Volume of Stem Cells Industry in United States by Downstream Industry 2013-2017
Table Demand Volume of Stem Cells Industry by Downstream Industry in New England 2013-2017
Table Demand Volume of Stem Cells Industry by Downstream Industry in The Middle Atlantic 2013-2017
Table Demand Volume of Stem Cells Industry by Downstream Industry in The Midwest 2013-2017
Table Demand Volume of Stem Cells Industry by Downstream Industry in The West 2013-2017
Table Demand Volume of Stem Cells Industry by Downstream Industry in The South 2013-2017
Table Demand Volume of Stem Cells Industry by Downstream Industry in Southwest 2013-2017
Table Demand Volume Forecast of Stem Cells Industry in United States by Downstream Industry 2018-2023
Table Sales Volume of Stem Cells Industry in United States by Major Players 2013-2017
Table Revenue of Stem Cells Industry in United States by Major Players 2013-2017
Table Headquarters Location and Established Time of Stem Cells Industry Major Players
Table Employees and Revenue Level of Stem Cells Industry Major Players
Table Representative Stem Cells Industry Product One of ViaCyte, Inc.
Table Representative Stem Cells Industry Product Two of ViaCyte, Inc.
Table Stem Cells Industry Sales, Revenue, Price and Gross Margin of ViaCyte, Inc. 2013-2017
Table Representative Stem Cells Industry Product One of Celgene Corporation
Table Representative Stem Cells Industry Product Two of Celgene Corporation
Table Stem Cells Industry Sales, Revenue, Price and Gross Margin of Celgene Corporation 2013-2017
Table Representative Stem Cells Industry Product One of Thermo Fisher Scientific
Table Representative Stem Cells Industry Product Two of Thermo Fisher Scientific
Table Stem Cells Industry Sales, Revenue, Price and Gross Margin of Thermo Fisher Scientific 2013-2017
Table Representative Stem Cells Industry Product One of Aastrom Biosciences, Inc.
Table Representative Stem Cells Industry Product Two of Aastrom Biosciences, Inc.
Table Stem Cells Industry Sales, Revenue, Price and Gross Margin of Aastrom Biosciences, Inc. 2013-2017
Table Representative Stem Cells Industry Product One of Osiris Therapeutics, Inc.
Table Representative Stem Cells Industry Product Two of Osiris Therapeutics, Inc.
Table Stem Cells Industry Sales, Revenue, Price and Gross Margin of Osiris Therapeutics, Inc. 2013-2017
Table Representative Stem Cells Industry Product One of Geron Corporation
Table Representative Stem Cells Industry Product Two of Geron Corporation
Table Stem Cells Industry Sales, Revenue, Price and Gross Margin of Geron Corporation 2013-2017
Table Representative Stem Cells Industry Product One of Vericel Corporation
Table Representative Stem Cells Industry Product Two of Vericel Corporation
Table Stem Cells Industry Sales, Revenue, Price and Gross Margin of Vericel Corporation 2013-2017
Table Representative Stem Cells Industry Product One of Astellas Pharma
Table Representative Stem Cells Industry Product Two of Astellas Pharma
Table Stem Cells Industry Sales, Revenue, Price and Gross Margin of Astellas Pharma 2013-2017
Table Representative Stem Cells Industry Product One of StemCells, Inc.
Table Representative Stem Cells Industry Product Two of StemCells, Inc.
Table Stem Cells Industry Sales, Revenue, Price and Gross Margin of StemCells, Inc. 2013-2017
Table Representative Stem Cells Industry Product One of Cytori Therapeutics, Inc.
Table Representative Stem Cells Industry Product Two of Cytori Therapeutics, Inc.
Table Stem Cells Industry Sales, Revenue, Price and Gross Margin of Cytori Therapeutics, Inc. 2013-2017
Table Representative Stem Cells Industry Product One of Pluristem Therapeutics Inc.
Table Representative Stem Cells Industry Product Two of Pluristem Therapeutics Inc.
Table Stem Cells Industry Sales, Revenue, Price and Gross Margin of Pluristem Therapeutics Inc. 2013-2017
Table Representative Stem Cells Industry Product One of Mesoblast Ltd.
Table Representative Stem Cells Industry Product Two of Mesoblast Ltd.
Table Stem Cells Industry Sales, Revenue, Price and Gross Margin of Mesoblast Ltd. 2013-2017
Table Representative Stem Cells Industry Product One of Athersys
Table Representative Stem Cells Industry Product Two of Athersys
Table Stem Cells Industry Sales, Revenue, Price and Gross Margin of Athersys 2013-2017
Table Representative Stem Cells Industry Product One of Fate Therapeutics Inc.
Table Representative Stem Cells Industry Product Two of Fate Therapeutics Inc.
Table Stem Cells Industry Sales, Revenue, Price and Gross Margin of Fate Therapeutics Inc. 2013-2017
